Global growth outlook strengthens as MAPFRE Economics lifts 2025 forecast

MAPFRE Economics raised its 2025 global GDP forecast to 3.1% (0.2ppt higher) and kept 2026 at 3.0%, while projecting global inflation at 3.4% in 2025 easing to 3.0% in 2026. The report expects life insurance activity to expand 6.2% in 2025 and 6.5% in 2026, and non-life to rise 5.4% and 5.6% respectively, citing steadier economic conditions, improved financing and falling uncertainty; regional forecasts include the US at 1.8% growth (inflation 3.0%/2.6%) and China at 4.6%/4.2% (inflation roughly 0% this year, 0.8% next). These outlooks suggest a supportive backdrop for insurers’ product demand and planning, with tariffs seen as having limited near-term impact but greater effects possible in 2026.

Analysis

Market structure: Insurance (life and non-life) and capital-light reinsurers are net beneficiaries as MAPFRE projects life +6.2% in 2025 and non-life +5.4%, implying higher premium volumes and firmer pricing power for well-capitalized P&C carriers (e.g., CB, TRV) and large life writers (MET, PRU). Insurers with large investment portfolios gain from steadier growth and easing inflation that supports bond returns and annuity sales; small, EM-heavy carriers and undercapitalized specialty writers are the primary losers. Cross-asset: modestly tighter credit spreads and falling inflation expectations should push IG and long-duration sovereign yields lower by ~10–30bps in the next 3–6 months, reducing funding costs but raising duration risk on liability-heavy books.

Risk assessment: Tail risks include a sudden inflation re-acceleration (>+0.5pp YoY within 6 months), severe nat-cat waves (losses >2–3x 10-year avg), and adverse tariff shocks in 2026; any triggers could force reserve strengthening and equity drawdowns >25% in the sector. Immediate (days) impact is muted; short-term (weeks–months) risks occur around 2025 premium renewals and Q4 results; long-term (quarters–years) is exposure to EM inflation and liability duration mismatch. Hidden dependencies: insurer earnings hinge on 10y yield moves, reinsurance capacity pricing, and FX in LATAM where inflation remains elevated (8–9%).

Trade implications: Favor high-quality P&C and diversified life insurers—establish concentrated long positions in CB and MET (see decisions). Implement relative-value: overweight KIE (U.S. insurance ETF) vs underweight XLF for 6–12 months to capture sector outperformance. Use defined-risk options (6–9 month call spreads on CB, MET; sell short-dated calls against existing holdings if IV < historical by >20%) to express upside with capped downside. Rebalance if CPI surprises by ±0.5pp or 10y yield moves >30bps.

Contrarian angles: Consensus underestimates 2026 tariff risk and concentration of climate risk—markets may underprice reserve volatility and nat-cat tail risk. The rally could be underdone in well-capitalized global insurers but overdone in EM-focused franchises; historical parallel: post-2012 low-rate bounce helped insurers until sudden nat-cat years reversed gains. Unintended consequence: rising annuity demand could force life writers into lower-margin product mixes, compressing IRR on new business if yields stay low longer than expected.

Key Decisions for Investors

• Establish a 2–3% portfolio long split: 1.5% Chubb (CB) and 1.5% MetLife (MET) within 2–6 weeks; target 12–18% total return over 12 months, hard stop-loss at -12% and trim on +15% gains. Rationale: diversified underwriting, strong balance sheets, benefit from stable growth and improving fixed-income returns.
• Implement a relative-value overweight of iShares U.S. Insurance ETF (KIE) +3% vs underweight Financial Select Sector SPDR (XLF) -2% for a 6–12 month window; rebalance if KIE outperforms XLF by >5% or if global growth forecast is downgraded by >0.3pp.
• Use options to express convex upside: buy 6–9 month call spreads on CB sized 0.5–1% notional (buy ATM, sell 10–15% OTM) to limit premium outlay; alternatively sell 45–60 day covered calls on existing MET/CB holdings if implied vol is >20% below 90-day historical vol.
• Trim EM/LATAM insurance exposure: reduce positions in holdings with >25% revenue from Latin America by ~40% within 30 days; further cuts if local CPI >9% or FX depreciation >10% versus USD within 90 days.